Hilleman Laboratories invests $80m in vaccine development hub

The new facility is the first of its kind in Singapore.

Hilleman Laboratories established a new vaccine development and manufacturing hub on 6 December. The project is supported by the Singapore Economic Development Board (EDB).

The hub will comprise a 30,000-square-foot current Good Manufacturing Practices (cGMP) facility at 138 Depot Road and a state-of-the-art research and development facility at Biopolis, which began operations in April 2021.

The company will invest close to $80m (US$58m) in operations, infrastructure, and capacity building over the next five years.

"Singapore is an important base for Hilleman Laboratories to expand in the region and beyond as we ramp up efforts to develop timely, novel, and affordable vaccines and biologics for infectious diseases, which exert a heavy burden on low- and middle-income countries. EDB's support strengthens our position as an end-to-end development organisation whilst lending our expertise in vaccines and biologics to build local capabilities to address urgent public health challenges caused by vaccine-preventable diseases, some of which have pandemic potential,” said CEO Raman Rao.

Hilleman Laboratories plans to leverage the local ecosystem in hiring up to 50 scientists, engineers, and managers in Singapore, offering training and career development opportunities and equipping them with the skills and expertise necessary to strengthen the country's capabilities in the development of vaccines and biologics, in compliance with global regulatory and quality standards.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

The loss will not have any material impact on the company.
Around 66 hotels have submitted to offer their rooms for hotel isolation.
He has been acting as group CEO since September 2021.
Bidding for these projects may commence in the first half of 2022.
Cardholders can now seek treatment from units where they did not register.
The system will be implemented this year.
The new facility will provide care for Indonesians who get treatment overseas.
The system was the only one of its kind in the country.
Healthcare Asia will be back on 3 January 2022. 
The additional patents aim to address supply issues.
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
Despite NCDs accounting for 41 million deaths annually, they are still healthcare's 'blind spot', expert says.
The gala was held in celebration of World AIDS Day 2021.
It won in the International Human-Machine Competition on Diabetes Management.
The new facility is the first of its kind in Singapore.